SCHEMBL2944324

SCHEMBL2944324

CC(C)(N)C(=O)Cl.CCN1C(=O)C(N)CCc2c1ccc([N+](=O)[O-])c2OC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.32
MAPT P10636 4/20 0.32
RECQL P46063 1/20 0.32
TP53 P04637 1/20 0.31
HTT P42858 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
INSR P06213 1/20 0.31
ALK Q9UM73 1/20 0.31
HPGD P15428 1/20 0.31
PSD A5PKW4 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
USP2 O75604 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062292 0.90 ALDH1A1 (0.37) ALDH1A1MAPTRECQLTP53HTT
SCHEMBL2944325 0.87 GAA (0.32) ALDH1A1MAPTRECQLTP53HTT
SCHEMBL2943806 0.78 ALDH1A1 (0.37) ALDH1A1MAPTRECQLMEN1KMT2A
SCHEMBL2062766 0.76 ALDH1A1 (0.36) ALDH1A1MAPTRECQLMEN1KMT2A
SCHEMBL2944853 0.76 F2 (0.34) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2938843 0.75 KDM4E (0.35) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2061895 0.72 POLB (0.38) ALDH1A1MAPTHTTHPGDCYP1A2
SCHEMBL2062829 0.71 ALK (0.40) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL2944328 0.68 SMN1; SMN2 (0.30)
SCHEMBL2062625 0.63 F10 (0.37) HTTUSP2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed